Interesting strategy. GILD is looking a little overbought right now anyway with macd possibly turning down, the next couple days should tell. Short term, I would cover if it broke 69. It will be interesting to see how their stock price reacts to the news of leronlimab partnering with someone else. But to me, I would give odds at 10%-15%, that Gilead makes a move. You would had to go short and the announcement be them or wait until the day of announcement.